Home / Current Issue / Paper 1718701
Heartbeat of Hope:Saving Mothers' Lives through Effective Pre-eclampsia Management
Subject area: Science,Engineering and Technology · Area of research: Maternal and Child Health
Abstract
Background: Pre-eclampsia (PE) is a multisystem hypertensive disorder of pregnancy, typically presenting after 20 weeks of gestation with hypertension and proteinuria. It contributes significantly to maternal and perinatal morbidity and mortality, accounting for over 50,000 maternal deaths and 500,000 fetal deaths annually. The burden is disproportionately high in sub-Saharan Africa, including Nigeria, where prevalence ranges from 2–16% and maternal mortality ratios exceed 1,000 per 100,000 live births. Objectives: This narrative review, Heartbeat of Hope: Saving Mothers’ Lives through Effective Pre-eclampsia Management, aims to examine the burden, risk factors, and pathophysiology of PE; evaluate diagnostic biomarkers and screening tools; explore clinical management and preventive strategies and identify barriers and propose solutions for Nigeria and similar resource-limited settings. Methods: Evidence was synthesized from peer-reviewed studies, WHO guidelines, and meta-analyses published between 2021 and 2025, with emphasis on African and Nigerian data. Results: PE complicates 3–5% of pregnancies globally, with higher incidence in low-resource settings. Risk factors include primigravidity, advanced maternal age, obesity, diabetes, and family history. Diagnostic advances such as the sFlt-1/PlGF ratio, uterine artery Doppler, and angiogenic biomarkers improve predictive accuracy beyond traditional blood pressure and proteinuria measures. Preventive strategies—low-dose aspirin, calcium supplementation, and lifestyle interventions—reduce risk in high-risk women. Management relies on antihypertensives, magnesium sulfate for seizure prophylaxis, and timely delivery. In Nigeria, barriers include poor antenatal coverage, limited access to diagnostic tools, shortages of essential medicines, and inadequate provider training. Conclusion: Effective PE management requires integration of advanced diagnostics, preventive interventions, and evidence-based treatment within strengthened health systems. In Nigeria, scaling up antenatal care, training frontline providers, ensuring magnesium sulfate availability, and community education are critical to reducing maternal mortality. Addressing these barriers aligns with the Sustainable Development Goal of reducing maternal deaths to fewer than 70 per 100,000 live births by 2030.
Keywords
diagnostic biomarkers, magnesium sulfate, maternal mortality, Pre-eclampsia, preventive strategies
How to cite this paper
@article{1718701,
author = {Osintona Ronke Rebecca , Abiodun -Ojo Oluwabukola Esther },
title = {Heartbeat of Hope:Saving Mothers' Lives through Effective Pre-eclampsia Management},
journal = {Iconic Research And Engineering Journals},
year = {2026},
volume = {9},
number = {12},
pages = {4088-4091},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1718701.pdf},
abstract = {Background: Pre-eclampsia (PE) is a multisystem hypertensive disorder of pregnancy, typically presenting after 20 weeks of gestation with hypertension and proteinuria. It contributes significantly to maternal and perinatal morbidity and mortality, accounting for over 50,000 maternal deaths and 500,000 fetal deaths annually. The burden is disproportionately high in sub-Saharan Africa, including Nigeria, where prevalence ranges from 2–16% and maternal mortality ratios exceed 1,000 per 100,000 live births.
Objectives: This narrative review, Heartbeat of Hope: Saving Mothers’ Lives through Effective Pre-eclampsia Management, aims to examine the burden, risk factors, and pathophysiology of PE; evaluate diagnostic biomarkers and screening tools; explore clinical management and preventive strategies and identify barriers and propose solutions for Nigeria and similar resource-limited settings.
Methods: Evidence was synthesized from peer-reviewed studies, WHO guidelines, and meta-analyses published between 2021 and 2025, with emphasis on African and Nigerian data.
Results: PE complicates 3–5% of pregnancies globally, with higher incidence in low-resource settings. Risk factors include primigravidity, advanced maternal age, obesity, diabetes, and family history. Diagnostic advances such as the sFlt-1/PlGF ratio, uterine artery Doppler, and angiogenic biomarkers improve predictive accuracy beyond traditional blood pressure and proteinuria measures. Preventive strategies—low-dose aspirin, calcium supplementation, and lifestyle interventions—reduce risk in high-risk women. Management relies on antihypertensives, magnesium sulfate for seizure prophylaxis, and timely delivery. In Nigeria, barriers include poor antenatal coverage, limited access to diagnostic tools, shortages of essential medicines, and inadequate provider training.
Conclusion: Effective PE management requires integration of advanced diagnostics, preventive interventions, and evidence-based treatment within strengthened health systems. In Nigeria, scaling up antenatal care, training frontline providers, ensuring magnesium sulfate availability, and community education are critical to reducing maternal mortality. Addressing these barriers aligns with the Sustainable Development Goal of reducing maternal deaths to fewer than 70 per 100,000 live births by 2030.},
keywords = {diagnostic biomarkers, magnesium sulfate, maternal mortality, Pre-eclampsia, preventive strategies},
month = {June},
}